Prediction: 2 Space Stocks That Could Join SpaceX and Rocket Lab in the Nasdaq-100 by 2030

The article identifies AST SpaceMobile and Intuitive Machines as speculative candidates to join the Nasdaq-100 by 2030, alongside current constituents SpaceX and Rocket Lab. AST SpaceMobile has delayed commercial direct-to-device satellite service from late 2026 to early 2027, while Intuitive Machines reported $206 million in quarterly revenue and expects more than $1 billion of 2026 sales. Blue Origin, valued at roughly $140 billion, could qualify for Nasdaq-100 inclusion if it pursues an IPO, though all forecasts depend on uncertain commercialization of satellite and lunar-economy businesses.

Analysis

The investable implication is not index inclusion but financing durability: ASTS and LUNR remain valued primarily on milestones whose cash requirements precede recurring cash generation. For ASTS, each deployment or commercialization slip increases dilution risk and strengthens the incumbent distribution advantage held by Starlink and mobile-network partners that can bundle alternative satellite connectivity. For LUNR, revenue conversion is less important than contract mix, fixed-price execution and backlog quality; a headline revenue ramp can still be cash-negative if mission overruns or working-capital needs absorb the gross profit.

RKLB is the cleaner listed beneficiary of sustained space-capex because it monetizes launches, spacecraft systems and government procurement today, while its vertically integrated stack can capture delays or supplier bottlenecks affecting less mature operators. A second-order risk is that a highly valued public SpaceX, if independently confirmed, would reset public-market comparables: it could expand the sector multiple initially but ultimately compress RKLB's strategic-scarcity premium and make ASTS/LUNR look inexpensive only if their execution probability rises materially.

The article's index-membership framing is a weak trading signal and should not be underwritten without verifying index eligibility, listing status, float and market-cap data. Over the next 1-3 months, launch results, regulatory approvals, contracted capacity and financing terms matter more than retail narrative; over 6-18 months, the key separation will be recurring service gross margin for ASTS versus contract-funded backlog and cash conversion for LUNR. Falsification for a constructive ASTS view is another schedule reset or equity raise before commercial service; for LUNR, it is backlog growth without operating-cash-flow improvement or a material mission failure.

Key Decisions for Investors

• Prefer a 6-12 month long RKLB / short equal-dollar LUNR pair. RKLB offers broader monetization of government and commercial demand, while LUNR carries concentrated mission, customer and working-capital risk; reassess if LUNR demonstrates two consecutive quarters of positive operating cash flow and backlog conversion.
• Keep ASTS on a catalyst watch rather than initiate on index speculation. Consider a small long only after independently verified launch success, regulatory clearance and disclosed funding sufficient to reach initial service without another equity raise; use a stop on any revised commercialization timetable or discounted capital raise.
• For existing space exposure, cap combined ASTS/LUNR gross exposure and fund it from higher-beta thematic allocations rather than core technology holdings. These names are likely to trade on financing and milestone probability, not on near-term earnings revisions, making downside gaps materially larger than implied by broad-market beta.
• Verify the reported SPCX public listing, Nasdaq-100 membership and investable float before using it as a comp or trading vehicle. If verified, monitor its valuation against RKLB: a sustained widening of SPCX's revenue/EBITDA premium without corresponding RKLB contract wins would argue for reducing RKLB rather than chasing sector beta.